$MKZR
Mackenzie Realty Capital Inc

2020 Q2 Form 10-K Financial Statement

#000114036121032741 Filed on September 28, 2021

View on sec.gov

Income Statement

Concept 2020 Q2 2020 2019 Q2
Revenue $1.310M $3.469M $3.370M
YoY Change -61.13% -38.54% 132.41%
Cost Of Revenue $690.0K $3.140M $1.230M
YoY Change -43.9% -33.19% -29.71%
Gross Profit $620.0K $5.590M $2.130M
YoY Change -70.89% -22.14% -810.0%
Gross Profit Margin 47.33% 161.15% 63.2%
Selling, General & Admin $290.0K $1.080M $150.0K
YoY Change 93.33% 18.68% -16.67%
% of Gross Profit 46.77% 19.32% 7.04%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization
YoY Change
% of Gross Profit
Operating Expenses $450.0K $5.261M $360.0K
YoY Change 25.0% -15.8% 44.0%
Operating Profit $170.0K $328.9K $1.770M
YoY Change -90.4% -64.69% -421.82%
Interest Expense -$5.340M -$15.19M -$930.0K
YoY Change 474.19% 450.36% -112.24%
% of Operating Profit -3141.18% -4618.2% -52.54%
Other Income/Expense, Net $0.00
YoY Change
Pretax Income -$5.170M $3.469M $850.0K
YoY Change -708.24% -38.39% -87.94%
Income Tax $0.00 $0.00 $0.00
% Of Pretax Income 0.0% 0.0%
Net Earnings -$5.170M -$11.73M $850.0K
YoY Change -708.24% -506.36% -87.94%
Net Earnings / Revenue -394.66% -338.02% 25.22%
Basic Earnings Per Share -$0.96
Diluted Earnings Per Share -$0.40 -$0.96 $0.08
COMMON SHARES
Basic Shares Outstanding 12.20M
Diluted Shares Outstanding 12.20M

Balance Sheet

Concept 2020 Q2 2020 2019 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments $9.000M $9.000M $1.300M
YoY Change 592.31% 592.31% -84.52%
Cash & Equivalents $8.957M $9.000M $1.279M
Short-Term Investments
Other Short-Term Assets
YoY Change
Inventory
Prepaid Expenses
Receivables $1.100M $1.100M $3.200M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $10.10M $10.10M $4.500M
YoY Change 124.44% 124.44% -68.53%
LONG-TERM ASSETS
Property, Plant & Equipment
YoY Change
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments $50.20M $50.20M $64.80M
YoY Change -22.53% -22.53% -13.02%
Other Assets $43.80M $43.80M $38.90M
YoY Change 12.6% 12.6% 12866.67%
Total Long-Term Assets $94.07M $94.10M $103.9M
YoY Change -9.46% -9.43% 37.98%
TOTAL ASSETS
Total Short-Term Assets $10.10M $10.10M $4.500M
Total Long-Term Assets $94.07M $94.10M $103.9M
Total Assets $104.2M $104.2M $108.4M
YoY Change -3.91% -3.87% 20.98%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $100.0K $100.0K $200.0K
YoY Change -50.0% -50.0%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $800.0K $800.0K $4.500M
YoY Change -82.22% -82.22% 36.36%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $100.0K $100.0K $700.0K
YoY Change -85.71% -85.71% 16.67%
Total Long-Term Liabilities $100.0K $100.0K $700.0K
YoY Change -85.71% -85.71% 16.67%
TOTAL LIABILITIES
Total Short-Term Liabilities $800.0K $800.0K $4.500M
Total Long-Term Liabilities $100.0K $100.0K $700.0K
Total Liabilities $941.0K $900.0K $5.200M
YoY Change -81.9% -82.69% 30.0%
SHAREHOLDERS EQUITY
Retained Earnings
YoY Change
Common Stock $1.284K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $103.2M $103.2M $103.1M
YoY Change
Total Liabilities & Shareholders Equity $104.2M $104.2M $108.4M
YoY Change -3.91% -3.87% 20.98%

Cashflow Statement

Concept 2020 Q2 2020 2019 Q2
OPERATING ACTIVITIES
Net Income -$5.170M -$11.73M $850.0K
YoY Change -708.24% -506.36% -87.94%
Depreciation, Depletion And Amortization
YoY Change
Cash From Operating Activities -$3.440M -$1.727M -$2.490M
YoY Change 38.15% -92.23% 398.0%
INVESTING ACTIVITIES
Capital Expenditures
YoY Change
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid $4.528M
YoY Change 19.38%
Common Stock Issuance & Retirement, Net $19.51M
YoY Change -16.08%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -660.0K 9.405M 1.990M
YoY Change -133.17% -37.54% -55.58%
NET CHANGE
Cash From Operating Activities -3.440M -1.727M -2.490M
Cash From Investing Activities
Cash From Financing Activities -660.0K 9.405M 1.990M
Net Change In Cash -4.100M 7.679M -500.0K
YoY Change 720.0% -207.19% -112.56%
FREE CASH FLOW
Cash From Operating Activities -$3.440M -$1.727M -$2.490M
Capital Expenditures
Free Cash Flow
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020Q4 us-gaap Accounts Payable And Other Accrued Liabilities
AccountsPayableAndOtherAccruedLiabilities
943805
CY2021Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
918449
CY2020Q2 us-gaap Accounts Payable And Accrued Liabilities Current And Noncurrent
AccountsPayableAndAccruedLiabilitiesCurrentAndNoncurrent
135040
CY2020Q2 us-gaap Accounts Receivable Gross
AccountsReceivableGross
1087432
CY2021 us-gaap Acquired Finite Lived Intangible Assets Weighted Average Useful Life
AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLife
P3Y1M6D
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
310400
CY2020 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
680000
CY2019 us-gaap Administrative Fees Expense
AdministrativeFeesExpense
570667
us-gaap Administrative Fees Expense
AdministrativeFeesExpense
310400
CY2019 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
556165
CY2020 us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
880138
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
342015
us-gaap Amortization Of Deferred Charges
AmortizationOfDeferredCharges
0
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1086486
us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
342015
CY2019 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
556165
CY2020 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
880138
CY2021Q2 us-gaap Assets
Assets
138553027
CY2020Q2 us-gaap Assets
Assets
104166764
CY2018Q2 us-gaap Assets Net
AssetsNet
85595319
CY2019Q2 us-gaap Assets Net
AssetsNet
103115381
CY2020Q2 us-gaap Assets Net
AssetsNet
103225721
CY2020Q4 us-gaap Assets Net
AssetsNet
97782730
CY2017Q2 us-gaap Assets Net
AssetsNet
59989525
CY2021Q2 us-gaap Below Market Lease Net
BelowMarketLeaseNet
838313
CY2021Q2 us-gaap Buildings And Improvements Gross
BuildingsAndImprovementsGross
38348005
CY2018 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.91
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-6399959
us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
5196119
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
-7163581
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect
7678725
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
14153512
CY2021Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
7753553
CY2018Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8442249
CY2019Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
1278668
CY2020Q2 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
8957393
CY2021Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
4833848
CY2020Q2 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
8957393
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
12539943
CY2017 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.78
CY2020 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.45
CY2019 us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.73
CY2021Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
13316426.79
CY2020Q2 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
12836608.02
CY2021Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q2 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Common Stock Value
CommonStockValue
1332
CY2020Q2 us-gaap Common Stock Value
CommonStockValue
1284
CY2021Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2020Q2 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
80000000
CY2021Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
13316426.79
CY2020Q2 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
12836608.02
CY2020Q2 us-gaap Cumulative Earnings Deficit
CumulativeEarningsDeficit
-13231163
CY2020Q2 us-gaap Deferred Offering Costs
DeferredOfferingCosts
278021
us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
2193953
us-gaap Depreciation And Amortization
DepreciationAndAmortization
2193953
us-gaap Dividend Income Equity Securities Operating
DividendIncomeEquitySecuritiesOperating
925948
CY2020 us-gaap Dividends Common Stock
DividendsCommonStock
5542591
us-gaap Dividends
Dividends
665317
CY2020 us-gaap Dividends
Dividends
5542591
CY2019 us-gaap Dividends
Dividends
7237635
us-gaap Dividends
Dividends
5525104
CY2021Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.05
CY2020Q2 us-gaap Dividends Payable Amount Per Share
DividendsPayableAmountPerShare
0.470
CY2021 us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2021-05-15
CY2020Q4 us-gaap Due From Affiliates
DueFromAffiliates
150866
CY2021Q2 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
1937
CY2020Q2 us-gaap Due To Other Related Parties Current And Noncurrent
DueToOtherRelatedPartiesCurrentAndNoncurrent
8492
CY2021Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
1937
CY2020Q2 us-gaap Due To Related Parties Current And Noncurrent
DueToRelatedPartiesCurrentAndNoncurrent
718264
CY2019 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-57437720
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-40083
CY2020 us-gaap Gain Loss On Investments
GainLossOnInvestments
-15194409
CY2019 us-gaap Gain Loss On Investments
GainLossOnInvestments
-2758599
us-gaap Gain Loss On Investments
GainLossOnInvestments
-9119286
us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-5204853
CY2021Q2 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
1086485
CY2021Q2 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
5141279
CY2021Q2 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
4054794
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.02
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
0.29
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.74
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.74
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.96
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.02
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
0.29
us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
1685130
CY2021Q2 us-gaap Equity Method Investments Fair Value Disclosure
EquityMethodInvestmentsFairValueDisclosure
40590394
us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-65129
CY2020 us-gaap Gain Loss On Sale Of Investments
GainLossOnSaleOfInvestments
-8057094
us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
139326
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-41846
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0
us-gaap Impairment Of Real Estate
ImpairmentOfRealEstate
0
CY2019 us-gaap Incentive Fee Expense
IncentiveFeeExpense
1789870
CY2020 us-gaap Incentive Fee Expense
IncentiveFeeExpense
0
us-gaap Incentive Fee Expense
IncentiveFeeExpense
0
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
3468857
us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
-547851
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments
IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments
5630758
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
354921
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
0
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-13348
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2708225
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-2082636
CY2019 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
-37153
CY2020 us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
0
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
340292
CY2020 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-80251
CY2019 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
198907
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
-48028
us-gaap Increase Decrease In Due From Related Parties
IncreaseDecreaseInDueFromRelatedParties
150866
CY2019 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
-3518
CY2020 us-gaap Increase Decrease In Deferred Liabilities
IncreaseDecreaseInDeferredLiabilities
0
us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-703660
CY2019 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
658857
CY2020 us-gaap Increase Decrease In Due To Related Parties
IncreaseDecreaseInDueToRelatedParties
-1747621
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
-180875
us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
-569221
us-gaap Interest Expense
InterestExpense
637691
us-gaap Interest Paid Net
InterestPaidNet
605018
CY2019 us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
17520062
us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
-5442991
CY2020 us-gaap Investment Company Net Assets Period Increase Decrease
InvestmentCompanyNetAssetsPeriodIncreaseDecrease
110340
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
-9667137
CY2019 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
2885507
CY2020 us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
-11725552
us-gaap Investment Company Net Assets From Operations Increase Decrease
InvestmentCompanyNetAssetsFromOperationsIncreaseDecrease
264157
CY2019 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0598
CY2018 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0306
CY2017 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0346
CY2020 us-gaap Investment Company Investment Income Loss Ratio
InvestmentCompanyInvestmentIncomeLossRatio
0.0336
CY2019 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
0.29
CY2020 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
-0.96
us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
-0.74
CY2018 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
1.45
CY2017 us-gaap Investment Company Net Asset Value Per Share Period Increase Decrease
InvestmentCompanyNetAssetValuePerSharePeriodIncreaseDecrease
1.03
CY2018 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.1479
CY2019 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.0306
CY2017 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
0.1067
CY2020 us-gaap Investment Company Total Return
InvestmentCompanyTotalReturn
-0.1137
CY2020 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.0510
CY2019 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.0662
CY2018 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.0652
CY2017 us-gaap Investment Company Incentive Fee To Average Net Assets
InvestmentCompanyIncentiveFeeToAverageNetAssets
0.0605
CY2018 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.30
CY2019 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.57
CY2020 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.28
CY2017 us-gaap Investment Company Investment Income Loss Per Share
InvestmentCompanyInvestmentIncomeLossPerShare
0.33
CY2019 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
11879290
us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
1881544
CY2020 us-gaap Investment Income Interest And Dividend
InvestmentIncomeInterestAndDividend
8729941
CY2019Q4 us-gaap Investment Company Distributable Earnings Loss Accumulated Appreciation Depreciation
InvestmentCompanyDistributableEarningsLossAccumulatedAppreciationDepreciation
4813649
us-gaap Investment Income Net
InvestmentIncomeNet
-547851
CY2020 us-gaap Investment Income Net
InvestmentIncomeNet
3468857
CY2019 us-gaap Investment Income Net
InvestmentIncomeNet
5644106
CY2020Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
93705145
CY2021Q2 us-gaap Investment Owned At Fair Value
InvestmentOwnedAtFairValue
70509243
CY2020Q2 us-gaap Investment Owned At Cost
InvestmentOwnedAtCost
104692648
CY2020Q2 us-gaap Investment Owned Percent Of Net Assets
InvestmentOwnedPercentOfNetAssets
0.9077
CY2021Q2 us-gaap Investments
Investments
105659988
CY2021Q2 us-gaap Investments Fair Value Disclosure
InvestmentsFairValueDisclosure
84536876
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Two Years
LessorOperatingLeasePaymentsToBeReceivedTwoYears
3154883
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Thereafter
LessorOperatingLeasePaymentsToBeReceivedThereafter
4758268
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Three Years
LessorOperatingLeasePaymentsToBeReceivedThreeYears
2976158
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Next Twelve Months
LessorOperatingLeasePaymentsToBeReceivedNextTwelveMonths
5351154
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received
LessorOperatingLeasePaymentsToBeReceived
21452742
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Four Years
LessorOperatingLeasePaymentsToBeReceivedFourYears
3051039
CY2021Q2 us-gaap Lessor Operating Lease Payments To Be Received Five Years
LessorOperatingLeasePaymentsToBeReceivedFiveYears
2161240
CY2021Q2 us-gaap Land
Land
16293591
CY2021Q2 us-gaap Liabilities
Liabilities
41190207
CY2020Q2 us-gaap Liabilities
Liabilities
941043
CY2021Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
138553027
CY2020Q2 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
104166764
CY2021Q2 us-gaap Long Term Debt
LongTermDebt
23568330
CY2019 us-gaap Management Fee Expense
ManagementFeeExpense
2206227
us-gaap Management Fee Expense
ManagementFeeExpense
1335376
CY2020 us-gaap Management Fee Expense
ManagementFeeExpense
2549076
us-gaap Management Fee Expense
ManagementFeeExpense
0
CY2021Q2 us-gaap Members Equity Attributable To Noncontrolling Interest
MembersEquityAttributableToNoncontrollingInterest
251840
CY2020Q4 us-gaap Members Capital
MembersCapital
8094236
CY2020Q2 us-gaap Members Equity
MembersEquity
103225721
CY2020Q4 us-gaap Noncurrent Assets
NoncurrentAssets
30196471
CY2020Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
8.04
CY2016Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.94
CY2017Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.84
CY2018Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
10.07
CY2019Q2 us-gaap Net Asset Value Per Share
NetAssetValuePerShare
9.44
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
14048927
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
15059067
us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
121593
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
9405365
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
970782
us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
3142438
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-22222648
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1726640
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-21419668
us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
1932088
us-gaap Net Investment Income
NetInvestmentIncome
-547851
CY2019 us-gaap Net Investment Income
NetInvestmentIncome
5644106
CY2020 us-gaap Net Investment Income
NetInvestmentIncome
3468857
us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
-14209
us-gaap Net Income Loss Available To Common Stockholders Basic
NetIncomeLossAvailableToCommonStockholdersBasic
264157
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
61600
CY2019 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
23333
us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
61600
CY2020 us-gaap Noninterest Expense Transfer Agent And Custodian Fees
NoninterestExpenseTransferAgentAndCustodianFees
80000
CY2019 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
58774
CY2020 us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
86507
us-gaap Noninterest Expense Printing And Fulfillment
NoninterestExpensePrintingAndFulfillment
70528
CY2019 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
707589
us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
6679
CY2020 us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
588203
us-gaap Noninterest Expense Investment Advisory Fees
NoninterestExpenseInvestmentAdvisoryFees
0
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
34000
CY2019 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
64500
us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
36000
CY2020 us-gaap Noninterest Expense Directors Fees
NoninterestExpenseDirectorsFees
68000
CY2021Q2 us-gaap Notes Payable
NotesPayable
38693330
CY2020Q4 us-gaap Notes Payable
NotesPayable
23974545
CY2021Q2 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
5588942
us-gaap Operating Lease Lease Income Lease Payments
OperatingLeaseLeaseIncomeLeasePayments
3141111
us-gaap Operating Lease Variable Lease Income
OperatingLeaseVariableLeaseIncome
604004
us-gaap Operating Lease Lease Income
OperatingLeaseLeaseIncome
3745115
us-gaap Profit Loss
ProfitLoss
-9667137
CY2019 us-gaap Profit Loss
ProfitLoss
2885507
us-gaap Operating Expenses
OperatingExpenses
7198498
CY2019 us-gaap Operating Expenses
OperatingExpenses
6248532
us-gaap Operating Expenses
OperatingExpenses
2429395
CY2020 us-gaap Operating Expenses
OperatingExpenses
5261084
us-gaap Operating Income Loss
OperatingIncomeLoss
-3453383
CY2020Q2 us-gaap Other Assets
OtherAssets
138773
CY2019 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
126295
CY2020 us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
65292
us-gaap Other General And Administrative Expense
OtherGeneralAndAdministrativeExpense
31665
CY2019 us-gaap Other Expenses
OtherExpenses
0
us-gaap Other Expenses
OtherExpenses
0
CY2020 us-gaap Other Expenses
OtherExpenses
0
CY2020Q4 us-gaap Other Restricted Assets
OtherRestrictedAssets
837133
CY2019 us-gaap Partners Capital Account Redemptions
PartnersCapitalAccountRedemptions
2368035
CY2020 us-gaap Partners Capital Account Redemptions
PartnersCapitalAccountRedemptions
3194670
CY2021 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
18060
CY2020 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
1823648
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
408818
CY2021 us-gaap Payments For Repurchase Of Initial Public Offering
PaymentsForRepurchaseOfInitialPublicOffering
9870000
CY2019 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
107876237
us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
12685590
CY2020 us-gaap Payments For Purchase Of Securities Operating Activities
PaymentsForPurchaseOfSecuritiesOperatingActivities
45079613
us-gaap Payments Of Dividends
PaymentsOfDividends
461040
CY2020 us-gaap Payments Of Dividends
PaymentsOfDividends
4528343
CY2019 us-gaap Payments Of Dividends
PaymentsOfDividends
3793273
us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
9303745
us-gaap Payments To Acquire Partners Interest In Real Estate Partnership Net Of Cash Acquired
PaymentsToAcquirePartnersInterestInRealEstatePartnershipNetOfCashAcquired
28623637
CY2021Q2 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
20000000
CY2021Q2 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q2 us-gaap Prepaid Expense And Other Assets
PrepaidExpenseAndOtherAssets
332271
CY2021 us-gaap Proceeds From Issuance Of Common Stock Dividend Reinvestment Plan
ProceedsFromIssuanceOfCommonStockDividendReinvestmentPlan
11360000
us-gaap Proceeds From Equity Method Investment Dividends Or Distributions Return Of Capital
ProceedsFromEquityMethodInvestmentDividendsOrDistributionsReturnOfCapital
6001052
us-gaap Proceeds From Divestiture Of Businesses Net Of Cash Divested
ProceedsFromDivestitureOfBusinessesNetOfCashDivested
1932088
CY2021 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
130460000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
23244171
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
19505452
us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
218439
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
218439
us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
15125000
us-gaap Proceeds From Sale Of Other Investments
ProceedsFromSaleOfOtherInvestments
10506662
us-gaap Professional Fees
ProfessionalFees
136750
us-gaap Professional Fees
ProfessionalFees
235132
CY2020 us-gaap Professional Fees
ProfessionalFees
263868
CY2019 us-gaap Professional Fees
ProfessionalFees
145112
us-gaap Profit Loss
ProfitLoss
249948
CY2020 us-gaap Profit Loss
ProfitLoss
-11725552
CY2021Q2 us-gaap Real Estate And Accumulated Depreciation Initial Cost Of Land
RealEstateAndAccumulatedDepreciationInitialCostOfLand
16293591
CY2021Q2 us-gaap Real Estate And Accumulated Depreciation Initial Cost Of Buildings And Improvements
RealEstateAndAccumulatedDepreciationInitialCostOfBuildingsAndImprovements
38348005
CY2021Q2 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
1107466
CY2020Q2 us-gaap Real Estate Accumulated Depreciation
RealEstateAccumulatedDepreciation
0
CY2021Q2 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
57972635
CY2020Q4 us-gaap Real Estate Investment Property Net
RealEstateInvestmentPropertyNet
30196471
CY2021Q2 us-gaap Real Estate Investment Property Accumulated Depreciation
RealEstateInvestmentPropertyAccumulatedDepreciation
2257903
CY2021Q2 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
54641596
CY2020Q2 us-gaap Real Estate Gross At Carrying Value
RealEstateGrossAtCarryingValue
0
CY2021 us-gaap Real Estate Improvements
RealEstateImprovements
54641596
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
737332
CY2020 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
1799988
CY2019 us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
1204050
us-gaap Realized Investment Gains Losses
RealizedInvestmentGainsLosses
1016326
CY2019Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
109263200
CY2019Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
104719872
CY2018Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
92435844
CY2021Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
134120859
CY2020Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
128769486
CY2019Q4 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
121409289
CY2018Q4 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
98322307
CY2020Q1 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
127070974
CY2020Q4 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
133997317
CY2020Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
128607752
CY2019Q3 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
115998789
CY2021Q2 us-gaap Related Party Transaction Amounts Of Transaction
RelatedPartyTransactionAmountsOfTransaction
133648965
us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
406215
CY2021Q2 us-gaap Restricted Cash
RestrictedCash
2919705
CY2020Q4 us-gaap Restricted Cash
RestrictedCash
1613569
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
1932088
CY2021Q2 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-23298857
us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
3745115
CY2021 us-gaap Revenue Recognition Dividends
RevenueRecognitionDividends
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;">Dividends and Distributions</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0);">Dividends (and distributions, if any) to common stockholders are recorded on the date of declaration. The amount, if any, to be paid as a quarterly dividend (or distribution, if any) is approved quarterly by the Board of Directors and is generally based upon management's estimate of the Company's earnings for the quarter.</div></div>
CY2021 us-gaap Sec Schedule Iii Real Estate Accumulated Depreciation Depreciation Expense
SECScheduleIIIRealEstateAccumulatedDepreciationDepreciationExpense
1107466
CY2021Q2 us-gaap Sec Schedule Iii Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Buildings And Improvements
SECScheduleIIIRealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionBuildingsAndImprovements
0
CY2021Q2 us-gaap Sec Schedule Iii Real Estate And Accumulated Depreciation Costs Capitalized Subsequent To Acquisition Land
SECScheduleIIIRealEstateAndAccumulatedDepreciationCostsCapitalizedSubsequentToAcquisitionLand
0
CY2021Q2 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
10.00
CY2020Q4 us-gaap Sale Of Stock Price Per Share
SaleOfStockPricePerShare
7.85
CY2021 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
21720
CY2020Q4 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
504091.15
CY2020 us-gaap Sale Of Stock Number Of Shares Issued In Transaction
SaleOfStockNumberOfSharesIssuedInTransaction
1943646
us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
18060
CY2020 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
1823648
CY2019 us-gaap Sales Commissions And Fees
SalesCommissionsAndFees
2010015
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
us-gaap Stock Issued1
StockIssued1
204277
CY2020Q2 us-gaap Stock Repurchase Program Number Of Shares Authorized To Be Repurchased
StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased
351198.37
CY2016Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
5000000
CY2019Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
15000000
CY2016Q4 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
15000000
CY2020Q2 us-gaap Stock Repurchase Program Remaining Authorized Repurchase Amount1
StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1
3194670
us-gaap Stock Repurchased During Period Value
StockRepurchasedDuringPeriodValue
408818
us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
218439
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
23244171
CY2020 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
19505452
us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
204277
CY2020 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
2891349
CY2019 us-gaap Stock Issued During Period Value Dividend Reinvestment Plan
StockIssuedDuringPeriodValueDividendReinvestmentPlan
3006069
CY2021Q2 us-gaap Stockholders Equity
StockholdersEquity
97110980
CY2021Q2 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
97362820
CY2020Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
97782730
CY2020Q2 us-gaap Tax Basis Of Investments Unrealized Appreciation Depreciation Net
TaxBasisOfInvestmentsUnrealizedAppreciationDepreciationNet
-8012675
CY2020Q2 us-gaap Tax Basis Of Investments Gross Unrealized Appreciation
TaxBasisOfInvestmentsGrossUnrealizedAppreciation
4054329
CY2020Q2 us-gaap Tax Basis Of Investments Gross Unrealized Depreciation
TaxBasisOfInvestmentsGrossUnrealizedDepreciation
12067004
CY2020Q2 us-gaap Tax Basis Of Investments Cost For Income Tax Purposes
TaxBasisOfInvestmentsCostForIncomeTaxPurposes
101717821
CY2021Q2 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
120408505
CY2020Q2 us-gaap Temporary Equity Value Excluding Additional Paid In Capital
TemporaryEquityValueExcludingAdditionalPaidInCapital
116455600
us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-10135612
CY2019 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-3962649
CY2020 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-16994397
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: 'Times New Roman'; font-size: 10pt;"><div style="text-align: justify; color: rgb(0, 0, 0); font-style: italic;">Use of Estimates</div><div><br /></div><div style="text-align: justify; color: rgb(0, 0, 0);">The preparation of consolidated financial statements requires management to make estimates and assumptions that affect reported asset values, liabilities, revenues, expenses and unrealized gains (losses) on investments during the reporting period. Material estimates that are susceptible to change, and actual results could differ from those estimates.</div></div>
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13332535.70
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
9951815.67
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
13020208.16
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
12198040.44
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13332536
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
13020208
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
9951816
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
12198040
CY2017 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
5183166
CY2018 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
7440841
CY2021Q2 srt Real Estate And Accumulated Depreciation Amount Of Encumbrances
RealEstateAndAccumulatedDepreciationAmountOfEncumbrances
38693330
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2019 mrc Income Fee
IncomeFee
0
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
false
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2020Q2 mrc Capital Pending Acceptance
CapitalPendingAcceptance
87739
CY2021Q2 mrc Capital Pending Acceptance
CapitalPendingAcceptance
0
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-06-30
CY2021 dei Entity Registrant Name
EntityRegistrantName
MacKenzie Realty Capital, Inc.
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001550913
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--06-30
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2020Q4 dei Entity Public Float
EntityPublicFloat
0
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021Q3 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
13342821.24
mrc Stock Issued During Period Value Capital Contributions By Non Controlling Interest Holders
StockIssuedDuringPeriodValueCapitalContributionsByNonControllingInterestHolders
200000
mrc Stock Issued During Period Value To Redeem Subsidiary S Non Controlling Interest
StockIssuedDuringPeriodValueToRedeemSubsidiarySNonControllingInterest
3957115
CY2020 mrc Payments For Proceeds From Change In Capital Pending Acceptance
PaymentsForProceedsFromChangeInCapitalPendingAcceptance
580426
mrc Payments For Proceeds From Change In Capital Pending Acceptance
PaymentsForProceedsFromChangeInCapitalPendingAcceptance
87739
CY2019 mrc Payments For Proceeds From Change In Capital Pending Acceptance
PaymentsForProceedsFromChangeInCapitalPendingAcceptance
-21865
mrc Return Of Capital On Investments
ReturnOfCapitalOnInvestments
11486835
CY2019 mrc Return Of Capital On Investments
ReturnOfCapitalOnInvestments
19019276
CY2020 mrc Return Of Capital On Investments
ReturnOfCapitalOnInvestments
31368113
CY2020Q4 mrc Rents And Other Receivable
RentsAndOtherReceivable
197760
mrc Payment Of Selling Commissions And Fees
PaymentOfSellingCommissionsAndFees
9107
CY2019 mrc Payment Of Selling Commissions And Fees
PaymentOfSellingCommissionsAndFees
2045661
CY2020 mrc Payment Of Selling Commissions And Fees
PaymentOfSellingCommissionsAndFees
1796648
CY2019 mrc Redemption Of Common Stock
RedemptionOfCommonStock
2368035
CY2020 mrc Redemption Of Common Stock
RedemptionOfCommonStock
3194670
mrc Increase Decrease In Investment Income Rent And Other Receivables
IncreaseDecreaseInInvestmentIncomeRentAndOtherReceivables
252735
mrc Increase Decrease In Investment Income Rent And Other Receivables
IncreaseDecreaseInInvestmentIncomeRentAndOtherReceivables
447398
mrc Increase Decrease In Deferred Offering Costs
IncreaseDecreaseInDeferredOfferingCosts
36578
CY2019 mrc Increase Decrease In Deferred Offering Costs
IncreaseDecreaseInDeferredOfferingCosts
709871
CY2020 mrc Increase Decrease In Deferred Offering Costs
IncreaseDecreaseInDeferredOfferingCosts
717839
mrc Dividends Paid From Capital Gain
DividendsPaidFromCapitalGain
2415285
CY2021 mrc Realized Investment Carrying Value Adjustment Gains Losses
RealizedInvestmentCarryingValueAdjustmentGainsLosses
-21123112
mrc Dividends Paid From Ordinary Income
DividendsPaidFromOrdinaryIncome
3085298
CY2021 mrc Percentage Of Excise Tax On Catch Up Distributions Paid In The Subsequent Year
PercentageOfExciseTaxOnCatchUpDistributionsPaidInTheSubsequentYear
0.04
CY2020Q2 mrc Uncertain Tax Positions
UncertainTaxPositions
0
CY2021Q2 mrc Uncertain Tax Positions
UncertainTaxPositions
0
mrc Property Repairs And Maintenance Expense
PropertyRepairsAndMaintenanceExpense
2330455
mrc Assets Management Fee Expense
AssetsManagementFeeExpense
1354323
CY2020 mrc Assets Management Fee Expense
AssetsManagementFeeExpense
0
mrc Assets Management Fee Expense
AssetsManagementFeeExpense
0
CY2019 mrc Assets Management Fee Expense
AssetsManagementFeeExpense
0
CY2021Q2 mrc Investment Owned Security At Fair Value
InvestmentOwnedSecurityAtFairValue
39909838
CY2021Q2 mrc Unconsolidated Investment Non Security At Fair Value
UnconsolidatedInvestmentNonSecurityAtFairValue
30599405
CY2021Q2 mrc Deferred Rent Credit And Other Liabilities
DeferredRentCreditAndOtherLiabilities
738178
CY2021Q2 mrc Investment Income Rent And Other Receivable
InvestmentIncomeRentAndOtherReceivable
1985325
CY2021 mrc Amortization Period Of Deferred Offering Costs
AmortizationPeriodOfDeferredOfferingCosts
P12M
CY2019 mrc Investment Company Capital Share Transactions Period Increase Decrease Total
InvestmentCompanyCapitalShareTransactionsPeriodIncreaseDecreaseTotal
21872190
mrc Investment Company Capital Share Transactions Period Increase Decrease Total
InvestmentCompanyCapitalShareTransactionsPeriodIncreaseDecreaseTotal
4224146
CY2020 mrc Investment Company Capital Share Transactions Period Increase Decrease Total
InvestmentCompanyCapitalShareTransactionsPeriodIncreaseDecreaseTotal
17378483
mrc Noncontrolling Interest In Consolidated Subsidiary
NoncontrollingInterestInConsolidatedSubsidiary
-66652
mrc Income Fee
IncomeFee
0
CY2020 mrc Income Fee
IncomeFee
0
CY2021 mrc Number Of Components Advisory Fee Payable For Services
NumberOfComponentsAdvisoryFeePayableForServices
3
CY2021Q2 mrc Due To Related Parties Asset Management Fees
DueToRelatedPartiesAssetManagementFees
0
CY2020Q2 mrc Due To Related Parties Asset Management Fees
DueToRelatedPartiesAssetManagementFees
0
CY2021Q2 mrc Due To Related Parties Administrative Cost Reimbursements
DueToRelatedPartiesAdministrativeCostReimbursements
0
CY2020Q2 mrc Due To Related Parties Administrative Cost Reimbursements
DueToRelatedPartiesAdministrativeCostReimbursements
0
mrc Incurred Offering Costs Reimbursement
IncurredOfferingCostsReimbursement
0
mrc Incurred Offering Costs Reimbursement
IncurredOfferingCostsReimbursement
342015
CY2020 mrc Incurred Offering Costs Reimbursement
IncurredOfferingCostsReimbursement
444935
mrc Subordinated Incentive Advisory Fees
SubordinatedIncentiveAdvisoryFees
0
CY2019 mrc Subordinated Incentive Advisory Fees
SubordinatedIncentiveAdvisoryFees
1789870
mrc Subordinated Incentive Advisory Fees
SubordinatedIncentiveAdvisoryFees
0
CY2020 mrc Subordinated Incentive Advisory Fees
SubordinatedIncentiveAdvisoryFees
0
mrc Number Of Advisory Agreements
NumberOfAdvisoryAgreements
2
CY2021 mrc Related Party Price Paid For Securities Purchased
RelatedPartyPricePaidForSecuritiesPurchased
4260459
CY2021 mrc Number Of Securities Ownership Is Increased
NumberOfSecuritiesOwnershipIsIncreased
2
CY2021 mrc Number Of Investment Funds
NumberOfInvestmentFunds
2
CY2019 mrc Incurred Offering Costs Reimbursement
IncurredOfferingCostsReimbursement
550908
CY2020Q2 mrc Due To Related Parties Organization And Offering Cost
DueToRelatedPartiesOrganizationAndOfferingCost
52492
CY2021Q2 mrc Due To Related Parties Organization And Offering Cost
DueToRelatedPartiesOrganizationAndOfferingCost
0
CY2019 mrc Capital Gain Fee
CapitalGainFee
1789870
CY2020 mrc Capital Gain Fee
CapitalGainFee
0
mrc Capital Gain Fee
CapitalGainFee
0
CY2021Q2 mrc Due To Related Parties Portfolio Structuring Fee
DueToRelatedPartiesPortfolioStructuringFee
0
CY2020Q2 mrc Due To Related Parties Portfolio Structuring Fee
DueToRelatedPartiesPortfolioStructuringFee
0
CY2021Q2 mrc Due To Related Parties Asset Acquisition Fees
DueToRelatedPartiesAssetAcquisitionFees
0
CY2021Q2 mrc Due To Related Parties Management Fees
DueToRelatedPartiesManagementFees
0
CY2020Q2 mrc Due To Related Parties Management Fees
DueToRelatedPartiesManagementFees
657280
CY2020Q2 mrc Due To Related Parties Subordinated Incentive Fee
DueToRelatedPartiesSubordinatedIncentiveFee
0
CY2021Q2 mrc Due To Related Parties Subordinated Incentive Fee
DueToRelatedPartiesSubordinatedIncentiveFee
0
CY2020Q2 mrc Due To Related Parties Transfer Agent Cost Reimbursements
DueToRelatedPartiesTransferAgentCostReimbursements
0
CY2021Q2 mrc Due To Related Parties Transfer Agent Cost Reimbursements
DueToRelatedPartiesTransferAgentCostReimbursements
0
CY2021 mrc Offering Cost Amortization Period
OfferingCostAmortizationPeriod
P12M
CY2020 mrc Asset Acquisition Fees
AssetAcquisitionFees
0
mrc Asset Acquisition Fees
AssetAcquisitionFees
343750
CY2019 mrc Asset Acquisition Fees
AssetAcquisitionFees
0
mrc Asset Acquisition Fees
AssetAcquisitionFees
0
mrc Dividends Paid From Return Of Capital
DividendsPaidFromReturnOfCapital
24521
CY2019Q4 mrc Sales Commissions And Dealer Manager Fees
SalesCommissionsAndDealerManagerFees
1.00
CY2020Q2 mrc Sales Commissions And Dealer Manager Fees
SalesCommissionsAndDealerManagerFees
1.03
CY2017Q2 mrc Average Assets Net
AverageAssetsNet
50160858
CY2019Q2 mrc Average Assets Net
AverageAssetsNet
94355350
CY2020Q2 mrc Average Assets Net
AverageAssetsNet
103170551
CY2018Q2 mrc Average Assets Net
AverageAssetsNet
72792422
CY2017 mrc Investment Company Realized Gain Loss On Investment Per Share
InvestmentCompanyRealizedGainLossOnInvestmentPerShare
0.31
CY2018 mrc Investment Company Realized Gain Loss On Investment Per Share
InvestmentCompanyRealizedGainLossOnInvestmentPerShare
0.36
CY2020 mrc Investment Company Realized Gain Loss On Investment Per Share
InvestmentCompanyRealizedGainLossOnInvestmentPerShare
0.15
CY2019 mrc Investment Company Realized Gain Loss On Investment Per Share
InvestmentCompanyRealizedGainLossOnInvestmentPerShare
0.12
CY2019Q2 mrc Investment Company Stock Outstanding
InvestmentCompanyStockOutstanding
10926320
CY2018Q2 mrc Investment Company Stock Outstanding
InvestmentCompanyStockOutstanding
8496142
CY2017Q2 mrc Investment Company Stock Outstanding
InvestmentCompanyStockOutstanding
6096773
CY2020Q2 mrc Investment Company Stock Outstanding
InvestmentCompanyStockOutstanding
12836608
CY2017 mrc Investment Company Redemption Of Common Stock
InvestmentCompanyRedemptionOfCommonStock
0.02
CY2019 mrc Investment Company Redemption Of Common Stock
InvestmentCompanyRedemptionOfCommonStock
0.02
CY2018 mrc Investment Company Redemption Of Common Stock
InvestmentCompanyRedemptionOfCommonStock
0.01
CY2020 mrc Investment Company Redemption Of Common Stock
InvestmentCompanyRedemptionOfCommonStock
0.01
CY2018 mrc Investment Company Issuance Of Common Stock Per Share
InvestmentCompanyIssuanceOfCommonStockPerShare
-0.32
CY2019 mrc Investment Company Issuance Of Common Stock Per Share
InvestmentCompanyIssuanceOfCommonStockPerShare
-0.21
CY2017 mrc Investment Company Issuance Of Common Stock Per Share
InvestmentCompanyIssuanceOfCommonStockPerShare
-0.37
CY2020 mrc Investment Company Issuance Of Common Stock Per Share
InvestmentCompanyIssuanceOfCommonStockPerShare
0
CY2020 mrc Investment Company Unrealized Gain Loss On Investment Per Share
InvestmentCompanyUnrealizedGainLossOnInvestmentPerShare
-1.39
CY2018 mrc Investment Company Unrealized Gain Loss On Investment Per Share
InvestmentCompanyUnrealizedGainLossOnInvestmentPerShare
0.79
CY2017 mrc Investment Company Unrealized Gain Loss On Investment Per Share
InvestmentCompanyUnrealizedGainLossOnInvestmentPerShare
0.39
CY2019 mrc Investment Company Unrealized Gain Loss On Investment Per Share
InvestmentCompanyUnrealizedGainLossOnInvestmentPerShare
-0.40
CY2021 mrc Non Cancelable Leases Average Remaining Term Of Amortization
NonCancelableLeasesAverageRemainingTermOfAmortization
P5Y
mrc Income From Equity Method Investments At Fair Value
IncomeFromEquityMethodInvestmentsAtFairValue
745562
mrc Accretion Of Market Lease And Other Intangibles Net
AccretionOfMarketLeaseAndOtherIntangiblesNet
-35187
mrc Increase Decrease In Deferred Rent And Other Liabilities
IncreaseDecreaseInDeferredRentAndOtherLiabilities
285850
mrc Capital Contributions By Non Controlling Interest Holders
CapitalContributionsByNonControllingInterestHolders
200000
CY2021Q2 mrc Shares Authorized
SharesAuthorized
100000000
CY2021 mrc Number Of Residential Apartment Buildings To Acquire And Operate
NumberOfResidentialApartmentBuildingsToAcquireAndOperate
2
CY2021 mrc Number Of Operating Companies Formed With Non Controlling Interest Holders
NumberOfOperatingCompaniesFormedWithNonControllingInterestHolders
2
CY2021 mrc Portfolio Risk Concentration Percentage
PortfolioRiskConcentrationPercentage
0.2

Files In Submission

Name View Source Status
0001140361-21-032741-index-headers.html Edgar Link pending
0001140361-21-032741-index.html Edgar Link pending
0001140361-21-032741.txt Edgar Link pending
0001140361-21-032741-xbrl.zip Edgar Link pending
brhc10029252_10k.htm Edgar Link pending
brhc10029252_ex10-6.htm Edgar Link pending
brhc10029252_ex31-1.htm Edgar Link pending
brhc10029252_ex31-2.htm Edgar Link pending
brhc10029252_ex32-1.htm Edgar Link pending
brhc10029252_ex32-2.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
mrc-20210630.xml Edgar Link completed
mrc-20210630.xsd Edgar Link pending
mrc-20210630_cal.xml Edgar Link unprocessable
mrc-20210630_def.xml Edgar Link unprocessable
mrc-20210630_lab.xml Edgar Link unprocessable
mrc-20210630_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending